Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain.

cebranopadol (GRT6005) - Assertio, Grunenthal

Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain. (clinicaltrials.gov) - Aug 8, 2022 - P1 | N=30 | Recruiting | Sponsor: Tris Pharma, Inc.
New P1 trial • Pain

http://clinicaltrials.gov/ct2/show/NCT05491785

Aug 8, 2022